DTIL

#3743
Precision BioSciences, Inc. Common Stock
7.52 USD
+4.01%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
7.52
7.54
Range Annuel
3.53
8.82
Changement quotidien
+4.01%
Changement Mensuel
+32.63%
Evolution sur 6 mois
+14.63%
Changement Annuel
+36.48%
Clôture Précédente
7.23
Open
7.52
Bid
Ask
Low
7.52
High
7.54
Volume
12
Open full chart

Financials

Overview Relevé Statistics
Quarterly Annual
Income statement Balance sheet Cash flow
Value Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25 TTM

Precision BioSciences Inc

Precision BioSciences, Inc. is a publicly traded American clinical stage gene editing company headquartered in Durham, North Carolina. Founded in 2006, Precision is focused on developing both in vivo and ex vivo gene editing therapies using its proprietary "ARCUS" genome editing platform.

Nouvelles